Clinical Trials Browser

OTHER × Uveal Melanoma × Vorinostat × Clear all

NCT03022565 2020-02-06

Vorinostat in Patients With Class 2 High Risk Uveal Melanoma

Phase EARLY_PHASE1 Withdrawn

Uveal Melanoma